Menkes disease: Oral administration of glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) rescues the macular mouse

Abstract

Oral administration of CuGTSM extended the lifespan of Mo mice. Oral administration is attractive, but pharmaceutical studies are needed to reduce the adverse enteral effects.